JP2022508676A5 - - Google Patents

Info

Publication number
JP2022508676A5
JP2022508676A5 JP2021544961A JP2021544961A JP2022508676A5 JP 2022508676 A5 JP2022508676 A5 JP 2022508676A5 JP 2021544961 A JP2021544961 A JP 2021544961A JP 2021544961 A JP2021544961 A JP 2021544961A JP 2022508676 A5 JP2022508676 A5 JP 2022508676A5
Authority
JP
Japan
Prior art keywords
group
peptide
cosmetic composition
derivatives
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021544961A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022508676A (ja
Filing date
Publication date
Priority claimed from IT102018000009384A external-priority patent/IT201800009384A1/it
Application filed filed Critical
Publication of JP2022508676A publication Critical patent/JP2022508676A/ja
Publication of JP2022508676A5 publication Critical patent/JP2022508676A5/ja
Pending legal-status Critical Current

Links

JP2021544961A 2018-10-11 2019-10-10 皮膚の老化および光老化の処置および予防に有効なペプチド Pending JP2022508676A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102018000009384 2018-10-11
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application
PCT/IB2019/058641 WO2020075108A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Publications (2)

Publication Number Publication Date
JP2022508676A JP2022508676A (ja) 2022-01-19
JP2022508676A5 true JP2022508676A5 (enExample) 2022-10-18

Family

ID=65010824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021544961A Pending JP2022508676A (ja) 2018-10-11 2019-10-10 皮膚の老化および光老化の処置および予防に有効なペプチド

Country Status (13)

Country Link
US (1) US20210395305A1 (enExample)
EP (1) EP3863728B1 (enExample)
JP (1) JP2022508676A (enExample)
KR (1) KR20210075098A (enExample)
CN (1) CN112823039A (enExample)
AU (1) AU2019357261A1 (enExample)
BR (1) BR112021006742A2 (enExample)
CA (1) CA3115025A1 (enExample)
EA (1) EA202190888A1 (enExample)
IL (1) IL282064B (enExample)
IT (1) IT201800009384A1 (enExample)
SG (1) SG11202103026YA (enExample)
WO (1) WO2020075108A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000020287A1 (it) * 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
KR102773595B1 (ko) * 2021-05-28 2025-02-27 주식회사 엘지생활건강 세노모르픽스용 또는 피부 노화 방지용 조성물
KR102726837B1 (ko) * 2021-09-29 2024-11-07 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102774179B1 (ko) * 2021-09-29 2025-03-04 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102877905B1 (ko) * 2021-09-30 2025-10-30 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102736940B1 (ko) * 2021-09-30 2024-12-03 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
JP2001527402A (ja) * 1997-04-25 2001-12-25 ジェネンテック,インコーポレーテッド Ngf変異体
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US6919426B2 (en) 2002-09-19 2005-07-19 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
UA97086C2 (uk) 2003-07-15 2012-01-10 Емджен, Інк. Виділене людське антитіло, яке специфічно зв'язується з фактором росту нервової тканини (ngf)
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
MX2009010757A (es) * 2007-04-06 2010-02-24 Kai Pharmaceuticals Inc Metodos de uso de compuestos de inhibidor gamma para atenuacion del dolor.
IT1394690B1 (it) * 2008-10-23 2012-07-13 Carli De Metodo di trattamento dermocosmetico della cute mediante applicazione di composizioni contenenti ngf.
KR101520333B1 (ko) * 2008-11-25 2015-05-14 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
KR20130031247A (ko) 2010-03-17 2013-03-28 애보트 리서치 비.브이. 항―신경 성장 인자(ngf) 항체 조성물
IE20100174A1 (en) * 2010-03-25 2012-02-29 Trinity College Dublin Transdermal administration of peptides
FR2961814B1 (fr) * 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
CA2818610C (en) * 2010-11-18 2020-02-18 Steven Yoelin Compositions and methods for hair growth
ITRM20110574A1 (it) * 2011-11-02 2013-05-03 Sampo S R L Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine.
BR112018005587A8 (pt) * 2015-09-22 2022-08-09 Currahee Holding Company Inc Métodos para aprimorar a aplicação tópica de um agente de benefício básico
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물
CN107286233B (zh) * 2016-04-13 2020-11-06 舒泰神(北京)生物制药股份有限公司 低痛神经生长因子突变体
CN107973848B (zh) * 2017-12-28 2020-10-16 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Similar Documents

Publication Publication Date Title
ES2682267T3 (es) Composición de alisado del pelo de una base no de hidróxido y un desnaturalizante de proteínas y procedimiento
CA2797847A1 (en) A composition for skin sanitization and protection and method of its use
WO2009068351A3 (en) Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k
JP2018528187A (ja) 表面改質用組成物
US20040241114A1 (en) Hair Care and Nail Care Compositions Based on Ion-Pair Delivery System for Gender and Ethnic Selective Applications
WO2002030367A8 (en) Scalp cosmetic and dermatological compositions
WO2007148831A1 (ja) 亜鉛を有効成分として含有するコラーゲン合成促進剤
WO2003061610A1 (en) Antimicrobial and sporicidal composition
JP2003212714A5 (enExample)
CA2256960A1 (en) High glycerin containing anti-microbial cleansers
AR009643A1 (es) Composiciones antimicrobianas para el cuidado personal
Philips et al. Abstracts: Direct inhibition of elastase and matrixmetalloproteinases and stimulation of biosynthesis of fibrillar collagens, elastin, and fibrillins by xanthohumol
JP2026004423A (ja) 皮膚及びその付属器の、ペプチドに基づいた化粧品又は皮膚科学的な処置
AU4521800A (en) Microemulsions and their use in finishing absorbent carrier substrates
BR9713576A (pt) Composição de barbear emétodo para prevenção de pesudofolliculitis barbae.
CN111936130B (zh) 包含锶和甲基磺酰基甲烷(msm)的局部制剂及治疗方法
JP2012522757A5 (enExample)
RU2118266C1 (ru) Композиция для усиления возобновления роста волос и/или для уменьшения выпадения волос
KR960033441A (ko) 천문동추출물 및 이를 함유하는 조성물
FR2681782A1 (fr) Composition pour le traitement des ongles contenant un aminoacide soufre.
DE602004004958D1 (de) Biphasiches Mittel und dessen Verwendungen in Kosmetika
JP7286908B2 (ja) 局所用組成物
BRPI0416966A (pt) uso de peptìdeos para proteção da pele contra composições para tratamento de cabelos
ES2224573T3 (es) 3-oxidos de 2-amino-4-alquilaminopirimidina como calmantes dermatologicos.
CN102762587A (zh) 新的调节存活蛋白的抗老化肽及包括其的组合物